Funded Projects › FP7
RISTOMED · New E-Services for a dietary approach to the elderly
Most nutraceutical SMEs have a limited access to the information needed for identifying the impact of their product at nutritional level. Also, the need of more personalized diets is an urgent requirement of EU healthcare systems,particularly for ageing and elderly people(EP).Nutraceuticals have different constraints not homogeneously defined in the EU Member States(MS)and their efficacy is always subordinate to the quality of the usual diet in different cultural scenarios.As a result,nutraceuticals are difficult to customize upon the needs of a specific market user, such as the EP, and their market is quite slow and fragmented. In response to these challenges,the goal of RISTOMED is to develop a new e-Health service for EP that will enable participant SMEs to penetrate the EP consumers market with the production of an innovative diet model. Biotech nutraceuticals,specifically designed and efficaciously delivered to the EP, will be integrated in biotech/ICT strategies coping with the complexity of nutritional specific requirements. RISTOMED brings together 8 partners distributed in 5 countries with a good balance between SMEs and RTDPs.In RISTOMED 3 biotech SMEs will collaborate with 4 RTDPs to solve the common problem of delivering innovative nutraceuticals for the control and prevention of the age-related diseases throughout new E-Health services.These services consist in the delivery of recipes and procedures containing nutraceuticals and probiotics specifically designed for EP and institutions dealing with EP throughout a new IT RISTOMED web platform(RWP).RWP will be developed by the ICT SME leading the consortium. The project result is expected to have a significant impact on the competitiveness of SME participants that will be able to expand their business by proposing to the market not only nutraceuticals but an integrated solution to better manage the diet and nutritional needs of EP to contrast inflammation,oxidative stress and gut microbiota alteration.
Consortium · 8 organisations
VOX NET SOCIETA COOPERATIVA
IT · €278,449
AISA THERAPEUTICS
FR · €234,373
LA MAISON DE L 'ARGAN
FR · €179,291
CHU HOPITAUX DE BORDEAUX
FR · €8,154
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
DE · €18,058
ACTIAL-FARMACEUTICA LDA
PT · €210,090
ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA
IT · €29,854
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
IT · €11,137
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.